Regulatory Work to Secure Licence Variation for anastrozole

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Contract (Services)
Duration
not specified
Value
£1
Sector
HEALTH
Published
27 May 2022
Delivery
not specified
Deadline
n/a

Concepts

Location

England

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.

Award Detail

1 Accord (Barnstaple)
  • Num offers: 3
  • Value: £1

Award Criteria

PRICE _

CPV Codes

  • 85149000 - Pharmacy services
  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

Price was not the only award criterion and all criteria were stated in the procurement documents

Reference

Domains